Drug Discovery
Accelerating the journey from laboratory breakthroughs to life-saving medications. Our drug discovery program integrates artificial intelligence, high-throughput screening, and preclinical development to deliver novel therapeutics for unmet medical needs.
AI-Driven Target Identification
Leveraging machine learning and computational biology to identify novel drug targets. Our AI platform analyzes genomic, proteomic, and clinical data to discover high-confidence targets with strong therapeutic potential.
Lead Compound Screening
High-throughput and virtual screening campaigns to identify promising lead compounds. We combine automated assay platforms with computational docking to efficiently explore chemical space.
Preclinical Development
Advancing drug candidates through ADMET profiling, pharmacokinetics, and toxicology studies. Our preclinical team optimizes drug-like properties and prepares candidates for clinical trials.
Computational Drug Design
Structure-based and ligand-based drug design using molecular dynamics simulations, free energy calculations, and generative chemistry models to optimize potency and selectivity.
Key Projects
AI Drug Design Platform
An integrated artificial intelligence platform for de novo drug design. Combining generative models with molecular simulation to design novel compounds with optimized pharmacological profiles.
Rare Disease Therapeutics
Dedicated to developing treatments for rare and orphan diseases. Our team identifies repurposing opportunities and designs novel therapies for conditions with limited treatment options.
Natural Product Screening
Mining natural product libraries from diverse biological sources for novel bioactive compounds. We combine traditional screening with genomics-guided approaches to discover hidden chemical diversity.
Leadership Team
Dr. Michael Torres
Director, Drug Discovery
Two decades of experience in pharmaceutical R&D, leading cross-functional teams from target identification through clinical candidate selection.
Dr. Aisha Patel
Senior Scientist, Drug Discovery
Expert in computational chemistry and AI-driven drug design, with a track record of delivering clinical candidates in oncology and neuroscience.
Collaborate With Us
Looking to partner on drug discovery or access our screening and computational platforms? We actively collaborate with pharmaceutical companies, biotech startups, and academic research groups.
Get in Touch